Cargando…
GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia
Recent studies highlighted the role of transcription factors in metabolic regulation during hematopoiesis and leukemia development. GFI1B is a transcriptional repressor that plays a critical role in hematopoiesis, and its expression is negatively related to the prognosis of acute myeloid leukemia (A...
Autores principales: | Liu, Longlong, Patnana, Pradeep Kumar, Xie, Xiaoqing, Frank, Daria, Nimmagadda, Subbaiah Chary, Su, Minhua, Zhang, Donghua, Koenig, Thorsten, Rosenbauer, Frank, Liebmann, Marie, Klotz, Luisa, Xu, Wendan, Vorwerk, Jan, Neumann, Felix, Hüve, Jana, Unger, Andreas, Okun, Jürgen Günther, Opalka, Bertram, Khandanpour, Cyrus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417998/ https://www.ncbi.nlm.nih.gov/pubmed/35804097 http://dx.doi.org/10.1038/s41375-022-01635-9 |
Ejemplares similares
-
High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia
por: Liu, Longlong, et al.
Publicado: (2022) -
Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition
por: Vorwerk, Jan, et al.
Publicado: (2022) -
Dose-dependent effect of GFI1 expression in the reconstitution and the differentiation capacity of HSCs
por: Xie, Xiaoqing, et al.
Publicado: (2023) -
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
por: Liu, Longlong, et al.
Publicado: (2022) -
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
por: Xie, Xiaoqing, et al.
Publicado: (2021)